Its application is critical in the development of new therapeutic agents, particularly those targeting cancer, because its boronic acid group can be used to selectively interact with biological targets. 4-(Pyridin-2-yl)aminocarbonylphenylboronic acid is used mainly as a key intermediate in the synthesis of pharmaceutical drugs, most notably as a building block for the anti-cancer medication acalabrutinib.
4-(Pyridin-2-yl)aminocarbonylphenylboronic acid
| API Name | Acalabrutinib |
|---|---|
| CAS No | 850568-25-1 |
| Molecular Formula | C12H11BN2O3 |
| Molecular Weight | 242.04 g/mol |
| Synonyms | [4-(pyridin-2-ylcarbamoyl)phenyl]boronic acid |
Zoho Contact Form
"*" indicates required fields